Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Deep Cellular and Molecular Characterization Reveal a Distinct Phenotype and Metabolic Signature of Human Senescent CD8 + T Cells: Implication for Cancer Cellular Therapy

Kevin Jan Jan Legscha, Lea Philine Märker, Najla Abassi, Abdul Yilmaz, Catherine Woelfel, Edite Antunes Ferreira, Annekathrin Nedwed, Sara Salome Helbich, Michael Delacher, Federico Marini, Stefan Porubsky, Matthias Theobald, Hakim Echchannaoui

Blood (2024) 144 (Supplement 1): 2536.

https://doi.org/10.1182/blood-2024-194719

Published: 2024

Journal Articles

Dual Inhibition of Histone and DNA Methylation in AML Enhances the Effectiveness of TCR-Based Cellular Therapy through Upregulation of Surface MHC Class I/p53 Antigen Complex

Ulrike Regina Schmits, Edite Antunes Ferreira, Borhane Guezguez, David Gomez-Zepeda, Stefan Tenzer, Kevin Jan Legscha, Matthias Theobald, Hakim Echchannaoui

Blood (2024) 144 (Supplement 1): 3444.

https://doi.org/10.1182/blood-2024-201347

Published: 2024

Journal Articles

The Menin Inhibitor Ziftomenib (KO-539) Synergizes with Agents Targeting Chromatin Regulation or Apoptosis and Sensitizes AML with MLL Rearrangement or NPM1 Mutation to Venetoclax

Johanna Rausch, Margarita M. Dzama, Nadezda Dolgikh, Hanna Stiller, Stephan Bohl, Catharina Lahrmann, Kerstin Kunz, Linda Kessler, Hakim Echchannaoui, Chun-Wei David Chen, Thomas Kindler, Francis Burrows, Matthias Theobald, Daniel Sasca, Scott A. Armstrong, Michael Kuehn

Blood (2022) 140 (Supplement 1): 6226–6227.

https://doi.org/10.1182/blood-2022-167566

Published: 2022

Journal Articles

p53 Isoform D133p53a: A Novel Transcriptional Enhancer of T-Cell Effector Function to Improve T-Cell Based Cancer Immunotherapy

Kevin Jan Legscha, MDcal Student, Edite Antunes, Research Assistant, Borhane Guezguez, BSc, MSc, PhD, Matthias Theobald, Hakim Echchannaoui, BSc, MSc, PhD

Blood (2018) 132 (Supplement 1): 3489.

https://doi.org/10.1182/blood-2018-99-116208

Published: 2018

Journal Articles

Interfering with Arginine Metabolism As a New Treatment Strategy for Multiple Myeloma

Bjoern Jacobi, MD, Lea Stroeher, MS, Nadine Leuchtner, Hakim Echchannaoui, PhD, Alexander Desuki, MD, Lara Kuerzer, Alice Habermeier, Edite Antunes, Eva Amann, John Bomalaski, MD, Closs Ellen, PhD Prof., Matthias Theobald, MD PhD, Markus Munder, MD

Blood (2015) 126 (23): 3005.

https://doi.org/10.1182/blood.V126.23.3005.3005

Published: 2015

Journal Articles

Gene Therapy With a High-Affinity Single-Chain p53-Specific TCR Mediates Potent Anti-Tumor Response Without Inducing Gvhd In Vivo

Hakim Echchannaoui, PhD, Jutta Petschenka, PhD student, Edite Antunes, Matthias Theobald, MD, PhD

Blood (2013) 122 (21): 1657.

https://doi.org/10.1182/blood.V122.21.1657.1657

Published: 2013

Journal Articles

Safe and Effective Adoptive T-Cell Receptor Transfer with a High Affinity Single Chain p53(264–272)-Specific TCR

Hakim Echchannaoui, PhD, Jutta Petschenka, PhD student, Edite Antunes, Matthias Theobald, MD, PhD

Blood (2012) 120 (21): 4226.

https://doi.org/10.1182/blood.V120.21.4226.4226

Published: 2012

NARROW

Deep Cellular and Molecular Characterization Reveal a Distinct Phenotype and Metabolic Signature of Human Senescent CD8 + T Cells: Implication for Cancer Cellular Therapy

Dual Inhibition of Histone and DNA Methylation in AML Enhances the Effectiveness of TCR-Based Cellular Therapy through Upregulation of Surface MHC Class I/p53 Antigen Complex

The Menin Inhibitor Ziftomenib (KO-539) Synergizes with Agents Targeting Chromatin Regulation or Apoptosis and Sensitizes AML with MLL Rearrangement or NPM1 Mutation to Venetoclax

p53 Isoform D133p53a: A Novel Transcriptional Enhancer of T-Cell Effector Function to Improve T-Cell Based Cancer Immunotherapy

Interfering with Arginine Metabolism As a New Treatment Strategy for Multiple Myeloma

Gene Therapy With a High-Affinity Single-Chain p53-Specific TCR Mediates Potent Anti-Tumor Response Without Inducing Gvhd In Vivo

Safe and Effective Adoptive T-Cell Receptor Transfer with a High Affinity Single Chain p53(264–272)-Specific TCR

Email alerts

ASH Publications

American Society of Hematology

Deep Cellular and Molecular Characterization Reveal a Distinct Phenotype and Metabolic Signature of Human Senescent CD8 + T Cells: Implication for Cancer Cellular Therapy

Dual Inhibition of Histone and DNA Methylation in AML Enhances the Effectiveness of TCR-Based Cellular Therapy through Upregulation of Surface MHC Class I/p53 Antigen Complex

The Menin Inhibitor Ziftomenib (KO-539) Synergizes with Agents Targeting Chromatin Regulation or Apoptosis and Sensitizes AML with MLL Rearrangement or NPM1 Mutation to Venetoclax

p53 Isoform D133p53a: A Novel Transcriptional Enhancer of T-Cell Effector Function to Improve T-Cell Based Cancer Immunotherapy

Interfering with Arginine Metabolism As a New Treatment Strategy for Multiple Myeloma

Gene Therapy With a High-Affinity Single-Chain p53-Specific TCR Mediates Potent Anti-Tumor Response Without Inducing Gvhd In Vivo

Safe and Effective Adoptive T-Cell Receptor Transfer with a High Affinity Single Chain p53(264–272)-Specific TCR

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only